| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Geratherm Medical AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.96 |
| 52 Week High | €7.35 |
| 52 Week Low | €3.84 |
| Beta | -0.0080 |
| 11 Month Change | -3.41% |
| 3 Month Change | -6.16% |
| 1 Year Change | -40.90% |
| 33 Year Change | -61.74% |
| 5 Year Change | -56.72% |
| Change since IPO | -59.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| GME | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.5% | 3.7% | 0.09% |
| 1Y | -40.9% | 4.1% | 3.1% |
Return vs Industry: GME underperformed the German Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: GME underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| GME volatility | |
|---|---|
| GME Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: GME has not had significant price volatility in the past 3 months.
Volatility Over Time: GME's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 191 | Christian Frick | www.geratherm.com |
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors.
Geratherm Medical AG Fundamentals Summary
| GME fundamental statistics | |
|---|---|
| Market cap | €21.84m |
| Earnings (TTM) | €1.11m |
| Revenue (TTM) | €21.60m |
19.7x
P/E Ratio1.0x
P/S RatioIs GME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GME income statement (TTM) | |
|---|---|
| Revenue | €21.60m |
| Cost of Revenue | €5.11m |
| Gross Profit | €16.49m |
| Other Expenses | €15.38m |
| Earnings | €1.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 76.36% |
| Net Profit Margin | 5.14% |
| Debt/Equity Ratio | 32.0% |
How did GME perform over the long term?
See historical performance and comparison